These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8739453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Recurrent spontaneous abortion of alloimmunologic etiology--diagnosis and immunotherapy].
    Malinowski A.
    Ginekol Pol; 2001 Nov; 72(11):885-98. PubMed ID: 11848031
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Passive immunotherapy with polyvalent immunoglobulins in women with habitual abortions].
    Mueller-Eckhardt G, Heine O, Turba H, Berghöfer A, Neppert J, Künzel W, Mueller-Eckhardt C.
    Beitr Infusionsther; 1990 Nov; 26():298-301. PubMed ID: 1703857
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA).
    Gharesi-Fard B, Zolghadri J, Foroughinia L, Tavazoo F, Samsami Dehaghani A.
    Iran J Immunol; 2007 Sep; 4(3):173-8. PubMed ID: 17767017
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis.
    Wang SW, Zhong SY, Lou LJ, Hu ZF, Sun HY, Zhu HY.
    Reprod Biomed Online; 2016 Dec; 33(6):720-736. PubMed ID: 27720163
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
    Malinowski A, Wilczynski J, Zeman K, Glowacka E, Kolasa D, Szpakowski A, Oszukowski P, Szpakowski M.
    Zentralbl Gynakol; 1998 Dec; 120(10):493-502. PubMed ID: 9823650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience.
    Mueller-Eckhardt G.
    Am J Reprod Immunol; 1994 Dec; 32(4):281-5. PubMed ID: 7718094
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunotherapy for recurrent spontaneous abortion.
    Coulam CB.
    Early Pregnancy; 1995 Mar; 1(1):13-26. PubMed ID: 9363231
    [Abstract] [Full Text] [Related]

  • 16. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
    Jablonowska B, Palfi M, Ernerudh J, Kjellberg S, Selbing A.
    Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion.
    Muyayalo KP, Li ZH, Mor G, Liao AH.
    Am J Reprod Immunol; 2018 Oct; 80(4):e13018. PubMed ID: 29984444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience.
    Christiansen OB.
    Am J Reprod Immunol; 1998 Feb; 39(2):77-81. PubMed ID: 9506205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.